HIV controllers: a multifactorial phenotype of spontaneous viral suppression
- PMID: 21865089
- PMCID: PMC3183253
- DOI: 10.1016/j.clim.2011.07.007
HIV controllers: a multifactorial phenotype of spontaneous viral suppression
Abstract
A small minority of HIV-infected individuals, known as HIV controllers, is able to exert long-term control over HIV replication in the absence of treatment. Increasing evidence suggests that the adaptive immune system plays a critical role in this control but also that a combination of several host and/or viral factors, rather than a single cause, leads to this rare phenotype. Here, we review recent advances in the study of these remarkable individuals. We summarize the epidemiology and clinical characteristics of HIV controllers, and subsequently describe contributing roles of host genetic factors, innate and adaptive immune responses, and viral factors to this phenotype. We emphasize distinctive characteristics of HIV-specific CD4 T cell responses and of CD4 T cell subpopulations that are frequently found in HIV controllers. We discuss major controversies in the field and the relevance of the study of HIV controllers for the development of novel therapeutic strategies and vaccines.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18. J Virol. 2010. PMID: 20719952 Free PMC article.
-
Mucosal immunity in HIV controllers: the right place at the right time.Curr Opin HIV AIDS. 2011 May;6(3):202-7. doi: 10.1097/COH.0b013e3283453e2b. Curr Opin HIV AIDS. 2011. PMID: 21399497 Free PMC article. Review.
-
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.Clin Infect Dis. 2010 Jul 15;51(2):233-8. doi: 10.1086/653677. Clin Infect Dis. 2010. PMID: 20550452 Free PMC article.
-
Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.Immunol Res. 2016 Jun;64(3):765-74. doi: 10.1007/s12026-015-8775-5. Immunol Res. 2016. PMID: 26724942
-
The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection.Front Immunol. 2021 Jul 21;12:695674. doi: 10.3389/fimmu.2021.695674. eCollection 2021. Front Immunol. 2021. PMID: 34367156 Free PMC article.
Cited by
-
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation.Cancer Immunol Immunother. 2013 Feb;62(2):285-97. doi: 10.1007/s00262-012-1334-1. Epub 2012 Aug 19. Cancer Immunol Immunother. 2013. PMID: 22903385 Free PMC article.
-
The natural history of HIV infection.Curr Opin HIV AIDS. 2013 Jul;8(4):311-7. doi: 10.1097/COH.0b013e328361fa66. Curr Opin HIV AIDS. 2013. PMID: 23698562 Free PMC article. Review.
-
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?Retrovirology. 2012 Sep 7;9:72. doi: 10.1186/1742-4690-9-72. Retrovirology. 2012. PMID: 22958464 Free PMC article. Review.
-
Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.J Virol. 2019 Feb 5;93(4):e01436-18. doi: 10.1128/JVI.01436-18. Print 2019 Feb 15. J Virol. 2019. PMID: 30487276 Free PMC article.
-
T-Follicular-Like CD8+ T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG.Front Immunol. 2022 Jun 15;13:928039. doi: 10.3389/fimmu.2022.928039. eCollection 2022. Front Immunol. 2022. PMID: 35784304 Free PMC article.
References
-
- Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27:406–416. - PubMed
-
- Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, Rouzioux C, Venet A, Delfraissy JF. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin Infect Dis. 2005;41:1053–1056. - PubMed
-
- Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, Hale B, Crum-Cianflone N, Delmar J, Barthel V, Quinnan G, Agan BK, Dolan MJ. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis. 2009;200:1714–1723. - PubMed
-
- Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol. 2009;83:329–335. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials